TITLE

Use of a risk scoring tool to identify higherrisk HIV-1 serodiscordant couples for an antiretroviral-based HIV-1 prevention intervention

AUTHOR(S)
Irungu, Elizabeth M.; Heffron, Renee; Mugo, Nelly; Ngure, Kenneth; Katabira, Elly; Bulya, Nulu; Bukusi, Elizabeth; Odoyo, Josephine; Asiimwe, Stephen; Tindimwebwa, Edna; Celum, Connie; Baeten, Jared M.
PUB. DATE
October 2016
SOURCE
BMC Infectious Diseases;10/17/2016, Vol. 16, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Antiretroviral therapy (ART) and pre-exposure prophylaxis (PrEP) reduce HIV-1 transmission within heterosexual HIV-1 serodiscordant couples. Prioritizing couples at highest HIV-1 transmission risk for ART and PrEP would maximize impact and minimize costs. Methods: The Partners Demonstration Project is an open-label, delivery study of integrated PrEP and ART for HIV-1 prevention among high risk HIV-1 serodiscordant couples in Kenya and Uganda. We evaluated the feasibility of using a validated risk score that weighs a combination of easily measurable factors (age, children, marital status, male circumcision status, condom use, plasma HIV-1 levels) to identify couples at highest risk for HIV-1 transmission for enrollment. Couples scoring ≥5 met the risk score eligibility criteria. Results: We screened 1694 HIV-1 serodiscordant couples and enrolled 1013. Of the screened couples, 1331 (78.6 %) scored ≥5 (with an expected incidence >3 % per year) and 76 % of these entered the study. The median age of the HIV-1 uninfected partner was 29 years [IQR 26, 36] and 20 % were <25 years of age. The HIV-1 uninfected partner was male in 67 % of partnerships, 33 % of whom were uncircumcised, 57 % of couples had no children, and 65 % reported unprotected sex in the month prior to enrollment. Among HIV-1 infected partners, 41 % had plasma viral load >50,000 copies/ml. Conclusion: A risk scoring tool identified HIV-1 serodiscordant couples for a demonstration project of PrEP and ART with high HIV-1 risk. The tool may be feasible for research and public health settings to maximize efficiency and minimize HIV-1 prevention costs.
ACCESSION #
119032311

 

Related Articles

  • Validation of self-report and hospital pill count using unannounced home pill count as methods for determination of adherence to antiretroviral therapy. MINZI, O. M. S.; NAAZNEEN, A. S. // Tanzania Journal of Health Research;Jun2008, Vol. 10 Issue 2, p84 

    Adherence to anti-retroviral therapy (ART) is very crucial for successful treatment outcomes. This study aimed to validate patient-self report (PSR) and hospital based pill count (HoPC) as adherence determination methods by using unannounced home visit pill count (HPC). The study was carried out...

  • Association of First-Line and Second-Line Antiretroviral Therapy Adherence. Ramadhani, Habib O.; Bartlett, John A.; Thielman, Nathan M.; Pence, Brian W.; Kimani, Stephen M.; Maro, Venance P.; Mwako, Mtumwa S.; Masaki, Lazaro J.; Mmbando, Calvin E.; Minja, Mary G.; Lirhunde, Eileen S.; Miller, William C. // Open Forum Infectious Diseases;Sep2014, Vol. 1 Issue 2, p1 

    Adherence to first-line ART is an important predictor of adherence to second-line ART. Improving adherence prior to switch is critical to improve patient outcomes.Background. Adherence to first-line antiretroviral therapy (ART) may be an important indicator of adherence to second-line ART....

  • Individualization of antiretroviral therapy - Pharmacogenomic aspect. Dalal, Bhavik; Shankarkumar, Aruna; Ghosh, K. // Indian Journal of Medical Research;Dec2015, Vol. 142 Issue 6, p663 

    Combination therapy with three drug regimens for human immunodeficiency virus (HIV) infection significantly suppresses the viral replication. However, this therapeutic impact is restricted by adverse drug events and response in terms of short and long term efficacy. There are multiple factors...

  • In silico modeling indicates the development of HIV-1 resistance to multiple shRNA gene therapy differs to standard antiretroviral therapy. Applegate, Tanya Lynn; Birkett, Donald John; Mcintyre, Glen John; Jaramillo, Angel Belisario; Symonds, Geoff; Murray, John Michael // Retrovirology;2010, Vol. 7, p83 

    Background: Gene therapy has the potential to counter problems that still hamper standard HIV antiretroviral therapy, such as toxicity, patient adherence and the development of resistance. RNA interference can suppress HIV replication as a gene therapeutic via expressed short hairpin RNAs...

  • Efficacy of 1998 Vs 2006 First-Line Antiretroviral Regimens for HIV Infection: An Ordinary Clinics Retrospective Investigation. Parruti, Giustino; Polilli, Ennio; De Socio, Giuseppe Vittorio; Sozio, Federica; Marconi, Patrizia; Soddu, Viviana; Dalessandro, Margherita; Celesia, Benedetto Maurizio; Pellicanò, Giovanni; Madeddu, Giordano; Vecchiet, Jacopo; Masi, Francesco Di; Mazzotta, Elena; Ursini, Tamara; Martinelli, Canio; Vitiello, Paola; Bonfanti, Paolo; Nigro, Luciano; Mura, Maria Stella; Antinori, Andrea // Journal of Antivirals & Antiretrovirals;2012, Vol. 4 Issue 2, p32 

    Purpose: The evidence suggesting increased HAART efficacy over time comes from randomized trials or cohort studies. This retrospective multicenter survey aimed to assess the variation over time in the efficacy and tolerability of first-line HAART regimens in unselected patients treated in...

  • Decreases in Community Viral Load Are Accompanied by Reductions in New HIV Infections in San Francisco. Das, Moupali; Chu, Priscilla Lee; Santos, Glenn-Milo; Scheer, Susan; Vittinghoff, Eric; McFarland, Willi; Colfax, Grant N. // PLoS ONE;2010, Vol. 5 Issue 6, p1 

    Background: At the individual level, higher HIV viral load predicts sexual transmission risk. We evaluated San Francisco's community viral load (CVL) as a population level marker of HIV transmission risk. We hypothesized that the decrease in CVL in San Francisco from 2004-2008, corresponding...

  • Clinical Profile of Neurological Manifestation in Human Immunodeficiency Virus-positive Patients. Sonkar, Satyendra K.; Gupta, Abhinav; Atam, Virendra; Chaudhary, Shyam C.; Tripathi, Anil K.; Sonkar, Gyanendra K. // North American Journal of Medical Sciences;Nov2012, Vol. 4 Issue 11, p596 

    The article presents a study that determines the neurological clinical profile of patients with human immunodeficiency virus (HIV). It states that the study was conducted at the Gandhi ward of the Department of Medicine of King George's Medical University in Lucknow, India. It also notes that...

  • Supersensitive Viral Load Assay in Predicting CD4-Guided Treatment Failure. Langford, Simone; Gayet-Ageron, Angele; Duncombe, Chris; Jupimai, Thidarat; Mahanontharit, Apicha; Kiertiburanakul, Sasisopin; Munsakul, Warangkana; Ruxrungtham, Kiat; Hirschel, Bernard; Ananworanich, Jintanat // Open Virology Journal;2008, Vol. 2, p69 

    In HIV patients who discontinue highly active antiretroviral therapy (HAART), the degree of HIV RNA suppression at the time of treatment interruption may predict success of re-treatment after the interruption (STI). A casecontrol substudy of the Staccato trial in Thailand included CD4-guided STI...

  • The Art of Managing Human Immunodeficiency Virus Infection: A Balancing Act. Reiss, Peter // Clinical Infectious Diseases;11/15/2009, Vol. 49 Issue 10, p1602 

    In this article the author discusses the management of HIV infection. He examines the use of combination antiretroviral therapy for treatment and prevention of HIV infection. He looks into the findings of the Tenofovir-Emtricitabine or Abacavir-Lamivudine (STEAL) trial which examines the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics